Delaware
|
68-0262011
|
|
(State or other jurisdiction of
|
(IRS Employer
|
|
incorporation)
|
Identification No.)
|
A copy of the Company's press release, entitled "Cerus Corporation Receives FDA Blood Products Advisory Committee Guidance for Proposed INTERCEPT Blood System Phase III Trial Design," is filed as Exhibit 99.1 hereto and is incorporated herein by reference.
Cerus Corporation
|
||||||||
Date: November 17, 2009
|
By:
|
/s/ Howard G. Ervin
|
||||||
Howard G. Ervin
|
||||||||
Vice President, Legal Affairs
|
||||||||
Exhibit No.
|
Description
|
|
EX-99.1
|
Press Release, dated November 16, 2009, entitled "Cerus Corporation Receives FDA Blood Products Advisory Committee Guidance for Proposed INTERCEPT Blood System Phase III Trial Design."
|